Tudóstér: Kovács Tünde publikációi

Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E., Sipos, A., Hegedűs, C., Uray, K., Nagy, P., Bai, P.: Identification of bacterial metabolites modulating breast cancer cell proliferation and epithelial-mesenchymal transition.
Molecules. 28 (15), 1-18, 2023.

Schwarcz, S., Kovács, P., Kovács, T., Ujlaki, G., Nyerges, P., Uray, K., Bai, P., Mikó, E.: The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models.
Mol. Biol. Rep. 50 (6), 5273-5282, 2023.

Režen, T., Rozman, D., Kovács, T., Kovács, P., Sipos, A., Bai, P., Mikó, E.: The role of bile acids in carcinogenesis.
Cell. Mol. Life Sci. 79 (5), 1-39, 2022.

Skaliczki, M., Lukács, B., Magyar, Z., Kovács, T., Bárdi, M., Novák, S., Diszházi, G., Sárközi, S., Márton, I., Péli-Szabó, J., Jóna, I., Nánási, P., Almássy, J.: 4-chloro-orto-cresol activates ryanodine receptor more selectively and potently than 4-chloro-meta-cresol.
Cell Calcium. 88 102213, 2020.

Nagy, L., Béke, F., Juhász, L., Kovács, T., Juhász-Tóth, É., Docsa, T., Tóth, A., Gergely, P., Somsák, L., Bai, P.: Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
PLoS One. 15 (9), 1-15, 2020.

Sári, Z., Mikó, E., Kovács, T., Jankó, L., Csonka, T., Lente, G., Sebő, É., Tóth, J., Tóth, D., Árkosy, P., Boratkó, A., Ujlaki, G., Török, M., Kovács, I., Szabó, J., Kiss, B., Méhes, G., Goedert, J., Bai, P.: Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress.
Cancers (Basel). 12 (9), 1-27, 2020.

Smolková, K., Mikó, E., Kovács, T., Leguina-Ruzzi, A., Sipos, A., Bai, P.: Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.
Antioxid. Redox Signal. 33 (13), 966-997, 2020.

Jankó, L., Sári, Z., Kovács, T., Kis, G., Szántó, M., Antal, M., Juhász, A., Bai, P.: Silencing of PARP2 blocks autophagic degradation.
Cells. 9 (2), 1-21, 2020.

Kovács, T., Mikó, E., Ujlaki, G., Sári, Z., Bai, P.: The Microbiome as a Component of the Tumor Microenvironment.
In: Tumor Microenvironment / Alexander Birbrair, Springer Nature - Springer Cham, Switzerland, 137-153, 2020, (dvances in Experimental Medicine and Biology, 0065-2598 ; 1225) ISBN: 9783030357269

Kovács, T., Mikó, E., Vida, A., Sebő, É., Tóth, J., Csonka, T., Boratkó, A., Ujlaki, G., Lente, G., Kovács, P., Tóth, D., Árkosy, P., Kiss, B., Méhes, G., Goedert, J., Bai, P.: Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors.
Sci Rep. 9 (1), 1-14, 2019.

Kovács, P., Csonka, T., Kovács, T., Sári, Z., Ujlaki, G., Sipos, A., Karányi, Z., Szeőcs, D., Hegedűs, C., Uray, K., Jankó, L., Kiss, M., Kiss, B., Laoui, D., Virág, L., Méhes, G., Bai, P., Mikó, E.: Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer.
Cancers (Basel). 11 1-31, 2019.

Mikó, E., Kovács, T., Sebő, É., Tóth, J., Csonka, T., Ujlaki, G., Sipos, A., Szabó, J., Méhes, G., Bai, P.: Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.
Cells. 8 (4), 1-33, 2019.

Vida, A., Kardos, G., Kovács, T., Bodrogi, B., Bai, P.: Deletion of poly(ADP?ribose) polymerase-1 changes the composition of the microbiome in the gut.
Mol. Med. Rep. 18 (5), 4335-4341, 2018.

Mikó, E., Vida, A., Kovács, T., Ujlaki, G., Trencsényi, G., Márton, J., Sári, Z., Kovács, P., Boratkó, A., Hujber, Z., Csonka, T., Antal-Szalmás, P., Watanabe, M., Gombos, I., Csóka, B., Kiss, B., Vígh, L., Szabó, J., Méhes, G., Sebestyén, A., Goedert, J., Bai, P.: Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.
Biochim. Biophys. Acta Bioenerg. 1859 (9), 958-974, 2018.

Dénes, N., Trencsényi, G., Nagy, G., Kis, A., Vida, A., Péli-Szabó, J., Farkas, F., Kovács, T., Bai, P., Berényi, E., Garai, I., Hunyadi, J., Kertész, I.: Application of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide derivates for preclinical melanoma modeling.
Eur. J. Nucl. Med. Mol. Imaging. 44 (S2), S630-S631, 2017.

Trencsényi, G., Dénes, N., Nagy, G., Kis, A., Vida, A., Farkas, F., Péli-Szabó, J., Kovács, T., Berényi, E., Garai, I., Bai, P., Hunyadi, J., Kertész, I.: Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging.
J. Pharmaceut. Biomed. Anal. 139 54-64, 2017.

Kertész, I., Vida, A., Nagy, G., Emri, M., Farkas, A., Kis, A., Angyal, J., Dénes, N., Péli-Szabó, J., Kovács, T., Bai, P., Trencsényi, G.: In Vivo Imaging of Experimental Melanoma Tumors Using The Novel Radiotracer 68Ga-NODAGA-Procainamide (PCA).
J. Cancer. 8 (5), 774-785, 2017.

Mikó, E., Kovács, T., Fodor, T., Bai, P.: Methods to assess to role of poly(ADP-ribose) polymerases in regulating mitochondrial oxidation.
Methods Mol. Biol. 1608 185-200, 2017.

Dénes, N., Trencsényi, G., Nagy, G., Kis, A., Vida, A., Farkas, F., Péli-Szabó, J., Kovács, T., Berényi, E., Garai, I., Bai, P., Hunyadi, J., Kertész, I.: Preclinical analysis of melanoma with ga-68 labeled procainamide derivatives.
Nucl. Med. Rev. Cent. East. Eur. 21 (2), 116, 2017.

Trencsényi, G., Nagy, G., Vida, A., Dénes, N., Péli-Szabó, J., Kovács, T., Garai, I., Bai, P., Varga, J., Kertész, I.: Comparative in vitro and in vivo studies of Ga-68-labeled melanin-specific Procainamide (PCA) using different chelators.
Eur. J. Nucl. Med. Mol. Imaging. 43 (Suppl.), S453, 2016.

Trencsényi, G., Nagy, G., Vida, A., Angyal, J., Dénes, N., Péli-Szabó, J., Kovács, T., Garai, I., Bai, P., Kertész, I.: Investigation of experimental melanoma tumors using the novel melanin specific radiotracer Ga-68-NODAGA-Procainamide (PCA).
Eur. J. Nucl. Med. Mol. Imaging. 43 (Suppl.), S452-S453, 2016.